AtaiBeckley (ATAI) Total Non-Current Liabilities (2020 - 2026)
AtaiBeckley (ATAI) posted quarterly Total Non-Current Liabilities of $897000.0 for Q1 2026.
Powered by 
Analysis
AtaiBeckley (ATAI) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends
AtaiBeckley has reported Total Non-Current Liabilities for 6 years, with the latest figure at $908000.0 in Q3 2025.
- Quarterly Total Non-Current Liabilities fell 97.88% year-over-year to $908000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $908000.0 (down 97.88% YoY) and the FY2022 annual result came in at $418000.0, down 69.69% from the prior year.
- Total Non-Current Liabilities for Q1 2026 stood at $897000.0.
- Over five years, Total Non-Current Liabilities peaked at $42.8 million in Q3 2024 and troughed at $412000.0 in Q1 2023.
- A 5-year average of $14.1 million and a median of $910000.0 in 2025 frame the typical range for Total Non-Current Liabilities.
- The sharpest annual moves came in 2024 and 2025: Total Non-Current Liabilities soared 9023.54% in 2024, then plunged 97.88% in 2025.
- Over 5 years, Total Non-Current Liabilities stood at $1.4 million in 2021, then plunged by 69.69% to $418000.0 in 2022, then surged by 7235.65% to $30.7 million in 2023, then surged by 39.66% to $42.8 million in 2024, then slumped by 97.88% to $908000.0 in 2025.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $908000.0, $910000.0, and $820000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 5.92 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 7.74 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 40.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 3.92 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 1.53 Bn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 1.88 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 4.20 Bn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 9.32 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 1.17 Bn |
| 10 | AtaiBeckley | 1.61 Bn | 1.61 Bn | - | 908,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 894,000.00 |
| Mar 31, 2026 | 897,000.00 |
| Sep 30, 2025 | 908,000.00 |
| Jun 30, 2025 | 910,000.00 |
| Mar 31, 2025 | 820,000.00 |
| Sep 30, 2024 | 42.83 Mn |
| Jun 30, 2024 | 38.99 Mn |
| Mar 31, 2024 | 37.59 Mn |
| Sep 30, 2023 | 30.43 Mn |
| Jun 30, 2023 | 30.66 Mn |
| Mar 31, 2023 | 412,000.00 |
| Dec 31, 2022 | 418,000.00 |
| Sep 30, 2022 | 425,000.00 |
| Jun 30, 2022 | 818,000.00 |
| Mar 31, 2022 | 843,000.00 |
| Dec 31, 2021 | 1.38 Mn |
| Dec 31, 2020 | 48,000.00 |